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Introductıon 
Frequently attributed as a hormone of bone 
metabolism, Vitamin D (VitD) has multiple 
regulatory effects on other systems such as 
cardiovascular system. Deficiencies of VitD have 
been associated with coronary heart disease, 
hypertension, and left ventricular hypertrophy (1). 
However the relationship of vitD status and 
invasive electrophysiologic properties has not 
been studied yet and also some controversial data 
arised (2-4). In this study we aimed to evaluate the 
effects of vitD levels on invasive 
electrophysiologic parameters and AF inducibility. 
ABSTRACT 
Objectives: Deficiencies of Vitamin D (VitD) has been 
associated with coronary heart disease, hypertension and 
left ventricular hypertropy. However its effects on 
cardiac conduction system and atrial fibrillation (AF) 
predisposition have not been studied yet. In this study we 
aim to evaluate the effects of VitD on invasive 
electrophysiologic parameters and AF inducibility. 
Materials and Methods: This retrospective cross-
sectional study included 135 patients. Study population 
was divided into three group as VitD sufficient, VitD 
insufficient and VitD deficient according to baseline vitD 
levels. Patients’ invasive electrophysiologic parameters 
and induced AF episodes were recorded. 
Results: Corrected sinus node recovery time, baseline 
cycle length, atrial-His interval, His-ventricular interval 
and Wenckebach cycle length were lengthened in vitD 
deficient group but they didn’t reach statistical 
significance. The rate of AF inducibility was twice as 
likely in VitD deficient group than sufficient group, 
however, it also didn’t reach statistical significance.  
Conclusion: Baseline VitD levels were not associated 
with cardiac electrophysiologic parameters and AF 
inducibility. To demonstrate the role of VitD in cardiac 
conduction system and AF inducibility thoroughly, 
further studies such as addressing VitD replacement are 
warranted.  
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ÖZET 
Amaç: Vitamin D (vit D) eksikliği, koroner kalp hastalığı, 
hipertansiyon ve sol ventrikül hipertrofisi ile ilişkili 
bulunmuştur. Ancak kardiyak iletim sistemi ve atriyal 
fibrilasyon (AF) yatkınlığına etkisi henüz 
araştırılmamıştır. Bu çalışmada, VitD'nin invaziv  
elektrofizyolojik parametreler ve AF indüklenebilirliği 
üzerindeki etkilerini değerlendirmeyi amaçladık.  
Gereç ve Yöntem: Bu retrospektif kesitsel çalışma 135 
hastayı içermektedir. Çalışma popülasyonu, temel vitD 
düzeylerine göre VitD yeterli, VitD yeters iz ve VitD 
eksikliği olmak üzere üç gruba ayrıldı. Hastaların invaziv 
elektrofizyolojik parametreleri ve uyarılan AF epizodları 
kaydedildi. 
Bulgular: Düzeltilmiş sinüs nodu iyileşme zamanı, bazal 
döngü uzunluğu, atriyal-His aralığı, His-ventriküler aralık 
ve Wenckebach siklus uzunluğu, vitD eksikliği olan 
grupta uzamış, ancak istatistiksel olarak anlamlı 
bulunmamıştır. AF indüklenebilirlik oranı, VitD eksikliği 
olan grupta, yeterli gruba göre iki kat daha fazlaydı., 
ancak istatistiksel olarak anlamlı değild i. 
Sonuç: Bazal VitD seviyeleri kardiyak elektrofizyolojik 
parametreler ve AF indüklenebilirliği ile ilişkili değildi. 
VitD'nin kardiyak iletim sistemindeki rolünü ve AF'nin 
indüklenebilirliğini tam olarak göstermek için VitD 
replasmanını da içeren daha ileri çalışmalar gereklidir. 
Anahtar Kelimeler: vitamin D, elektrofizyolojik 
parametreler, Atriyal fibrilasyon 
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Table 1. Baseline Characteristics of Study Population 
 VitD Deficient 
(n=94) 
VitD Insufficient 
(n=18) 
VitD Sufficient 
(n=23) 
p 
Female (%) 67 (71.2) 11 (61.1) 18 (78.2) 0.484 
Age, years 51.2±17.6 46.5±18.8 51.9±16.2 0.545 
LVEF, % 64.4±3.9 64.6±3.9 63.6±3.3 0.588 
LA, mm 34.6±1.7 35.5±2.4 35.3±2.0 0.890 
VitD, ng/mL 11.1±6.4 23.6±2.5 43.2±12.2 <0.001* 
Hemoglobin, g/dL 12.8±1.5 12.5±1.6 12.2±1.5 0.288 
Glucose, mg/dL 90.7±9.8 89.5±9.3 92.1±9.4 0.684 
Creatinine, mg/dL 0.8±0.2 0.9±0.2 0.9±0.2 0.520 
Potassium, mmol/dL 4.2±0.4 4.1±0.4 4.2±0.5 0.923 
*All pairwise correlations were significant at p<0.05 
Abbreviations: LA, left atrium; LVEF, left ventricular ejection fraction; VitD, vitamin D 
Materials and Methods 
In this retrospective cross-sectional study, we 
included a total of 135 patients who were suffered 
with undiagnosed repetitive palpitations and 
referred to our clinic for diagnostic cardiac 
electrophysiologic study (EPS) between January 
2015 and May 2017. Patients with structural heart 
disease, hypertension, diabetes, known sinus 
/atrioventricular nodal dysfunction, antiarrhytmic 
usage, thyroid or parathyroid diseases and calcium 
or vitD supplementation were excluded.  
Patients’ electrophysiology reports were carefully 
reviewed and patients’ corrected sinus node 
recovery times (cSNRT), baseline sinus cycle 
lengths (BCL), Wenckebach cycle length, atrial -
His (AH) and His-ventricular (HV) intervals and 
AF episodes were recorded. In all patients, AF 
was induced by burst atrial pacing and then 
categorized into sustained and nonsustained 
according to the duration (30 seconds). 
Demographic information and vitD measures 
were recorded. All VitD measurements were 
within the one-month window before the 
procedure. According to the Endocrinology 
Society Guidelines, study population was divided 
into three group as VitD sufficient (VitD≥ 
30ng/mL), VitD insufficient (VitD 21-29 ng/mL) 
and VitD deficient (VitD <20 ng/mL) (5). 
Local ethics committee approved the study 
protocol and informed consent was taken from all 
patients. 
Statistical Analysis: Continuous variables were 
presented as mean ± standard deviation, 
categorical variables were presented as 
percentages. Analysis of variance (ANOVA) test 
was used for statistical comparison of continuous 
variables.  χ2 test was used for comparison of 
categorical variables. A two-tailed P < 0.05 was 
considered statistically significant. All statistical 
analyses were performed using the SPSS 15 (SPSS 
INC, Chicago, Illinois, USA). We also performed 
post hoc power analysis to preclude type II error. 
Effect size for the parameter which had the most 
difference between the VitD groups was specified 
and post hoc study power was determined with 
0.05 type one error rate. Power analysis was 
carried out with G*Power 3.1.9.2. 
Results 
The study population was female predominant 
(71.1%) and had a mean age of 50. The 
demographic, laboratory and echocardiographic 
properties of groups were not statistically different 
(Table 1). cSNRT was increased 13% and 10% in 
VitD deficient and insufficient groups than 
sufficient group respectively. Similarly, BCL, 
Wenkebach cycle length, AH and HV intervals 
were increased in a similar but more attenuated 
fashion than cSNRT. However these differences 
did not meet statistical significance (Table 2). AF 
was two times likely inducible in VitD deficient 
patients than sufficient ones. However this 
difference also did not meet statistical significance 
(Table 2). With an effect size of 0.47 for cSNRT 
and with a type I error rate of 0.05, the study 
power was 99%. 
Discussion 
This study demonstrated that baseline VitD levels 
did not affect invasive electrophysiologic 
parameters and AF inducibility. To the best of our 
knowledge, this is the first study in the literature 
evaluating   the    effects    of   VitD    on   cardiac 
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Table 2. Comparison of the Groups’ Electrophysiologic Parameters 
 VitD Deficient 
(n=94) 
VitD Insufficient 
(n=18) 
VitD Sufficient 
(n=23) 
p 
cSNRT, msn 390.0±44.1 380.0±35.5 345.0±27.0 0.374 
BCL, msn 769.8±168.2 746.5±108.6 725.6±83.9 0.420 
Wenchebach, msn 331.5±44.0 326.6±34.9 319.1±12.7 0.389 
AH, msn 86.8±21.1 84.3±14.6 84.7±7.1 0.813 
HV, msn 44.3±7.7 44.0±5.6 42.6±2.4 0.564 
Inducible AF, n (%) 
  Nonsustained AF, n (%) 
  Sustained AF, n (%) 
16 (17.0 ) 
10 (10.6 ) 
6 (6.38) 
2 (11.1) 
0 (0.0) 
2 (11.1) 
2 (8.6) 
2 (8.6) 
0 (0.0) 
0.584 
 
Abbreviations: AF, Atrial fibrillation; AH, atrial-His interval; BCL, baseline sinus cycle length; cSNRT, corrected sinus node 
recovery time; HV, His-ventricular interval 
conduction system and AF inducibility. 
Deficiencies in VitD have been demonstrated as 
an emerging risk factor in cardiovascular diseases. 
Vitamin D exerts its cardiovascular functions by 
direct and indirect pathways. VitD receptors 
which are abundant in endothelium, vascular 
smooth muscle and cardiomyocytes are 
responsible for its direct cardiovascular effects 
while renin-angiotensin system (RAS) and 
inflammatory pathways are responsible for 
indirect effects. Studies have shown that vitamin 
D deficiency increases plasma renin activity, 
increases blood pressure, and has adverse effects 
on ventricular remodeling (4,6,7).  
The mechanism of arrhytmias in VitD deficiency 
can be explained by primarily due to its effects on 
cardiac repolarization. Mineralocorticoid receptor 
activation causes an increase in the inward calcium 
channel current and a decrease in the transient 
outward potassium current. These changes 
prolong the repolarization interval and cardiac 
action potential. Also vitD have a direct effect on 
cardiac repolarization (8-10). 
Previous studies investigated the possible 
mechanisms responsible for the relationship 
between VitD deficiency and AF. Deficiencies of 
VitD is associated with both structural and 
electrical atrial remodeling which are the 
consequences of increased TGFB1 expression, 
enhanced atrial fibrosis, and conduction 
heterogenity (11,12). Hanafy et al. demonstrated 
that replacement of VitD prolonged atrial action 
potential and therefore diminished AF inducibility 
and maximal AF rate in their animal study (13). 
Canpolat et al. showed that VitD deficiency 
prolonged atrial electromechanical delay which is 
an indicator for AF progression (14). Gode et al. 
reported that one ng/mL increase of VitD is 
associated with 15% decrease of postoperative AF 
odds in patients undergoing coronary artery 
bypass surgery (15). 
In our study, we evaluated the relationship 
between baseline VitD levels with invasive 
electrophysiologic parameters and AF inducibility 
and found that there were no significant 
differences existed. However, single measurement 
of vitD levels, seasonal variations (although our 
measurements were winter and spring time) may 
affect results. Also, apart from baseline levels, 
replacement of VitD may alter cardiac conduction 
times and AF inducibility. 
In conclusion, baseline VitD levels were not 
associated with cardiac electrophysiologic 
parameters and AF inducibility. To demonstrate 
the role of VitD in cardiac conduction system and 
AF inducibility thoroughly, further studies such as 
addressing VitD replacement are warranted.  
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